Clinical Pharmacology & Therapeutics · 2013 · 60 citations · 1 references
MedicineClinical PharmacyPharmacologyClinical PharmacologyHealthcare Quality ImprovementHiv PreventionAntiretroviral TherapyAntiviral PharmacologyHiv EpidemiologyHuman Immunodeficiency Virus PharmacotherapyPharmaceutical Quality AssuranceQuality Assurance In HealthcareClinical Pharmacology EvidenceClinical Pharmacology ReviewHiv Antiretroviral TherapyHiv Care Quality ImprovementImmune Cell ActivationImmune-mediated InflammationRegional Quality AssuranceResearch Agenda Setting
The global HIV epidemic continues to grow in certain regions while contracting in others, necessitating a broadened research agenda, including clinical pharmacology of tuberculosis, hepatitis, malaria, and immune activation/inflammation, underscoring the need for a coordinated quality assurance approach. A comprehensive program has been developed and implemented by the University at Buffalo HIV Clinical Pharmacology Quality Assurance and Quality Control Program, funded by the National Institutes of Health. Clinical Pharmacology & Therapeutics (2013); 93 6, 479-482. doi:10.1038/clpt.2013.62
1